Science & Technology
Science and Technology
Science and Technology 
Fri, September 9, 2011
Thu, September 8, 2011
The Law Firm of Levi & Korsinsky,;; LLP Announces Investigation of Caliper Life Sciences Inc.
NEW YORK--([ BUSINESS WIRE ])--Levi & Korsinsky is investigating the Board of Directors of Caliper Life Sciences Inc. (aCalipera or the aCompanya) (NASDAQ: CALP) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to PerkinElmer Inc. (NYSE: PKI). Under the terms of the transaction, Caliper shareholders will receive $10.50 per share of Caliper stock they own. The transaction has a total value of approximately $600 million.
Click here to learn more about the investigation: [ http://www.zlk.com/caliper-life-sciences-calp ], or call: 877-363-5972.
The investigation concerns whether the Caliper Board of Directors breached their fiduciary duties to Caliper stockholders by failing to adequately shop the Company before entering into this transaction and whether PerkinElmer Inc. is underpaying for Caliper shares, thus unlawfully harming Caliper stockholders.
If you own common stock in Caliper and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit [ http://www.zlk.com ].
Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.